SMS Lifesciences India Limited — Important, 13-11-2024: Financial Result Updates

SMS LifeSciences India Limited reported consolidated financial results for the quarter and half-year ended September 30, 2024.

**Revenue Growth:** The company posted total revenue of ₹8,050.04 crore for the quarter, reflecting a 15.7% increase year-over-year, driven by higher demand in the pharmaceutical sector and operational improvements. For the half-year, revenue reached ₹17,347.43 crore, up 7.7% from the previous year.

**Profit and EPS:** Net profit for the quarter was ₹330.03 crore, recovering from a loss of ₹44.25 crore in the same period last year. For the half-year, net profit stood at ₹1,039.66 crore, compared to a loss of ₹427.02 crore last year. EPS for the quarter and half-year were ₹15.46 and ₹38.60, respectively, indicating strong profitability growth.

**Operational Costs:** Total expenses rose to ₹7,579.64 crore for the quarter, a 11.6% increase year-on-year, largely due to spikes in material and employee costs. The firm managed to keep operational efficiency in check despite rising costs.

**Balance Sheet & Cash Flow:** Total assets increased to ₹39,140.33 crore, with a notable reduction in current liabilities indicating improved working capital management. Cash flow from operating activities showed healthy inflow, suggesting robust financial health.

**Strategic Position and Outlook:** The company is likely to focus on expanding its market presence and optimizing operational costs amidst improving profitability and cash flow.

**Investor Insight:** Given the significant turnaround in profitability, effective cost management, and positive operational outlook, the stock appears worth considering for accumulation.